![Manu Chakravarthy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Manu Chakravarthy formerly worked at Eli Lilly & Co., as Global Head-External Research & Development from 2015 to 2017, Axcella Health, Inc., as Chief Medical Officer & SVP-Clinical Development from 2017 to 2021, and Carmot Therapeutics, Inc., as Chief Scientific & Medical Officer from 2023 to 2024.
Dr. Chakravarthy received his undergraduate degree in 1995 from Saint John's University, doctorate degree from the University of Texas Graduate School of Biomedical Sciences, and doctorate degree from The University of Texas Medical School At Houston.
Anciens postes connus de Manu Chakravarthy
| Sociétés | Poste | Fin |
|---|---|---|
Carmot Therapeutics, Inc.
 Carmot Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops drugs for inflammatory, metabolic and neurological diseases | Directeur Technique/Scientifique/R&D | 01/05/2024 |
| AXCA HEALPAR | Directeur Technique/Scientifique/R&D | 05/03/2021 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/06/2017 |
Formation de Manu Chakravarthy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
31
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Saint John's University
 Saint John's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Carmot Therapeutics, Inc.
Carmot Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops drugs for inflammatory, metabolic and neurological diseases | Health Technology |
Axcella Health, Inc.
 Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
University of Texas Graduate School of Biomedical Sciences
 University of Texas Graduate School of Biomedical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas Medical School At Houston
 The University of Texas Medical School At Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
